Macau, China

Fenggen Yan

This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fenggen Yan. Retrieved from https://idiyas.com/inventor/fenggen-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Fenggen Yan

Introduction

Fenggen Yan is a notable inventor based in Macau, CN. He has made significant strides in the field of medical formulations, particularly in addressing thymus atrophy. His work is characterized by a commitment to enhancing therapeutic outcomes through innovative approaches.

Latest Patents

Fenggen Yan holds 1 patent for his invention titled "Development of a new formulation overcoming thymus atrophy with concomitantly enhancement of anti-inflammatory effect of dexamethasone." This invention provides a method for preventing and/or treating thymus degeneration by administering an effective amount of dihydromyricetin to a subject in need. The degeneration is often induced by dexamethasone during the treatment of inflammation.

Career Highlights

Fenggen Yan is affiliated with the Macau University of Science and Technology, where he contributes to research and development in his field. His academic and professional background has equipped him with the knowledge and skills necessary to innovate in medical science.

Collaborations

Fenggen Yan has worked alongside talented colleagues such as Liang Liu and Ting Li. Their collaborative efforts have furthered research initiatives and contributed to advancements in their respective areas of expertise.

Conclusion

Fenggen Yan's contributions to the field of medical formulations demonstrate his innovative spirit and dedication to improving health outcomes. His work continues to inspire future research and development in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…